The effect of socioeconomic deprivation on efficacy of continuous subcutaneous insulin infusion: a retrospective paediatric case-controlled survey

Abstract

Parental educational deprivation was associated with a failure of MDI but not CSII therapy. These outcomes need confirmation by larger studies.

Impact of neighbourhood‐level inequity on paediatric diabetes care

“…Similar to other studies linking socio‐economic status and metabolic control, our study demonstrated that this relationship may be partially mediated by differences in insulin regimen . We report that participants using insulin injection therapy had significantly lower NEI scores, on average, than those on pump therapy, and that the majority of pump users reside in neighbourhoods characterized by the least social inequity.…”

Young people with Type 1 diabetes of non‐white ethnicity and lower socio‐economic status have poorer glycaemic control in England and Wales

“…Cultural barriers might lead to less-effective communication between healthcare providers and minority ethnic families, especially those that do not have English as their first language. Another explanation is the lower insulin pump use among minority ethnic and lower SES groups [27]. However, accounting for pump use only marginally attenuated the observed ethnicity estimates.…”

Deprivation and ethnicity impact on diabetes control and use of treatment regimen

“…This might reflect a true biological difference, for example, haemoglobin glycosylation [14,15], or problem in engagement and understanding by healthcare professionals. The latter might also be an explanation for the lower pump therapy uptake, which has been suggested in other studies [16]. Alternatively, the cumulative stress that operates within certain ethnic groups might lead to alterations in allostatic load [17], which, by influencing cortisol secretion, would lead to differences in glucose regulation [18] and possibly views on health care and cognition [19].…”

“…The mean age was 10.6 years (range [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19], with an average duration of diabetes of 4.5 years. At each quarterly clinic visit, HbA 1c was measured, using the Siemens DCA1000 (Bayer) near-patient testing system (Siemens Healthcare Diagnostics Inc., Deerfield, IL, USA).…”